Related stories
Alembic Pharmaceuticals Q2 Consolidated Revenue INR 26,034.8 Million
M impact | EQUITY | Nov 04, 2026, 08:59 AM UTC
Alembic Pharmaceuticals Reports Q2 Consolidated Net Profit of INR 3,351.7 Million
M impact | EQUITY | Nov 04, 2026, 08:59 AM UTC
E-Life Mall Reports Third-Quarter Net Profit of NT$89.5 Million
E-Life Mall reported third-quarter net profit of NT$89.5 million, compared with NT$81.5 million a year earlier.
M impact | EQUITY | Nov 04, 2026, 08:58 AM UTC
Fosun International shares rise 5% on strong results
M impact | EQUITY | Nov 04, 2026, 08:58 AM UTC
Asker Healthcare Group Q3 2026 earnings call begins
Asker Healthcare Group's quarterly earnings call has begun.
M impact | EQUITY | Nov 04, 2026, 08:58 AM UTC
MCTA: Nasdaq trading halt continues — reason not given (3:58 AM ET)
Nasdaq kept trading halted in MCTA (reason not given) at 3:58 AM ET.
L impact | EQUITY | Nov 04, 2026, 08:58 AM UTC